ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355461; 2) Community: the network communities that were significantly associated with the response to NSC 355461; 3) Molecule: the relationships between components within communities and NSC 355461; 4) MDR: the compounds that were significantly associated with the NSC 355461.

NSC Compound Enrichment Correlation
NSC 174121 Methotrexate Derivative 0.0376362543535815 0.31897235
NSC 181500 Null 0.0376362543535815 0.35477787
NSC 271674 Carboxyphthalatoplatinum 0.0376362543535815 0.31999623
NSC 10660 Null 0.0382675857669585 0.14258547
NSC 146604 FUR 0.0382675857669585 0.32084817
NSC 154572 Null 0.0382675857669585 0.29079068
NSC 15628 Cinnasil 0.0382675857669585 0.27561093
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0382675857669585 0.2794341
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0382675857669585 0.10917658
NSC 251682 Jacaramome 0.0382675857669585 0.23662564
Total:57  Current:44    [First] [Prev] [Next] [Last]